Home // BioFabUSA // BioFabUSA News

BioFabUSA News

ReGen Valley: ‘The future of our country — really, the future of humanity — is being written right here in the Millyard’

Manchester Ink Link covers the groundbreaking of the ReGen workforce training center, a key milestone in advancing biofabrication and workforce development in the Millyard.

Statement from ARMI Board of Directors

February 5, 2026

Safi Biotherapeutics and ARMI | BioFabUSA Complete Successful Technical Transfer of Initial Clinical Scale 10L mRBC Production System

January 8, 2026

Kenai Therapeutics Receives $8M Grant from California Institute for Regenerative Medicine (CIRM) to Advance RNDP-001 for Treatment of Idiopathic Parkinson’s Disease

January 5, 2026

Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies

November 17, 2025

ReGen Valley about More Than an Industry, Southern NH Community Told

May 28, 2025

Exciting Partnership with the Museum of Science, Boston!

February 21, 2025

NH women leaders share what’s powered their careers

December 12, 2024

Aerial Image of Manchester Millyard ReGen Valley

ARMI Secures Grant to Help Biofabrication Research in Manchester

July 16, 2024

Manchester-Nashua biofab initiative looks to train, employ local people

May 28, 2024

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

BioFabUSA News

ReGen Valley: ‘The future of our country — really, the future of humanity — is being written right here in the Millyard’

Statement from ARMI Board of Directors

Safi Biotherapeutics and ARMI | BioFabUSA Complete Successful Technical Transfer of Initial Clinical Scale 10L mRBC Production System

Kenai Therapeutics Receives $8M Grant from California Institute for Regenerative Medicine (CIRM) to Advance RNDP-001 for Treatment of Idiopathic Parkinson’s Disease

Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies

ReGen Valley about More Than an Industry, Southern NH Community Told

Exciting Partnership with the Museum of Science, Boston!

NH women leaders share what’s powered their careers

ARMI Secures Grant to Help Biofabrication Research in Manchester

Manchester-Nashua biofab initiative looks to train, employ local people

Technology

Education & Workforce Development

Regulatory

Membership

Initiatives

BioFab Startup Lab

Request for Proposals (RFP)

Project Calls

Build Back Better